Sinovac shot prevents only 38% of Covid cases in kids, data shows

Sinovac shot prevents only 38% of Covid cases in kids, data shows

Third Sinovac shot found ineffective compared to mRNA vaccine booster

Nurses vaccinate a child against the Covid-19 coronavirus at a Pattani hospital on Feb 7, 2022. (AFP file photo)
Nurses vaccinate a child against the Covid-19 coronavirus at a Pattani hospital on Feb 7, 2022. (AFP file photo)

Young children who received two doses of China’s Sinovac Biotech Ltd vaccine gained “modest” defences against Omicron infections and higher protection against developing severe cases of Covid-19, a study in Chile showed.

Researchers, who tracked about 490,000 children ages 3 to 5 years, estimated the Sinovac shot has effectiveness rates of 38% against Covid-19, 65% against hospitalisation, and 69% against an infection severe enough to require admission to an intensive care unit. The study took place during the Omicron outbreak in Chile between December and February and was conducted by researchers, mostly working for local universities as well as the country’s health ministry. 

The results, which were uploaded as a preprint on Research Square, have not undergone peer review yet offer insights into how the vaccine fares against the more-transmissible variant. They also shed some light on the efficacy of Covid-19 vaccines in children, as the spread of Omicron led to more pediatric hospital admissions.

The rates of protection are substantially lower than recent preliminary estimates of the effectiveness of two doses of the Sinovac vaccine in children 6 to 16 years, when the Delta variant was predominant. In that study, the estimated effectiveness was 75% against Covid-19, 91% for the prevention of hospitalisation, and 94% against admission to an ICU.

Earlier lab studies from across the world have shown that Omicron significantly dented the effectiveness of various vaccines, including the more potent messenger RNA shots. Research from Hong Kong has found a booster dose of an mRNA vaccine can improve the protective levels of antibodies against Omicron, while a third Sinovac shot cannot.

Sinovac’s inactivated shot is one of the world’s most widely used Covid inoculations, with over 260 million doses administered as of mid-March. The vaccine has also been approved for use among children as young as three in 14 jurisdictions, ranging from mainland China and Hong Kong to Thailand and Brazil, according to the company.

Do you like the content of this article?
COMMENT (14)
TRENDING

Rising stars emerge at President's Cup 2022

The President’s Cup 2022 has been underway since last month at the Thai Polo & Equestrian Club, Pattaya, with Harald Link, president of the Thailand Equestrian Federation (TEF), declaring that the competition is truly back on track.

08:00

1,663 new Covid inpatients, 30 more deaths

The country registered 30 more Covid-19 fatalities and 1,663 new cases admitted to hospitals during the previous 24 hours, the Public Health Ministry announced on Monday morning.

07:51

EEC schemes to get govt hurry-up

Prime Minister Prayut Chan-o-cha will today chair a meeting of the Eastern Economic Corridor (EEC) Policy Committee to follow up on progress in investment projects.

07:07